NSN 6505-01-252-0802 (6505012520802) Clorazepate Dipotassium Tablets Usp Parts List

Alternative NSN: 6505-01-252-0802

Item Name:Clorazepate Dipotassium Tablets Usp

NIIN: 012520802

NCB Code: USA (01)

Manufacturers: Abbott Laboratories Inc , Actavis Inc , Danbury Pharmacal Inc , Mylan Pharmaceuticals Inc , Rugby Group Inc , Schein Henry Inc , Taro Pharmaceuticals Usa Inc , Warner Lambert Ltd

ASAP Aerospace, owned and operated by ASAP Semiconductor, is the latest parts procurement platform for the aerospace and aviation industry. Customers can easily search our database to find NSN parts like Clorazepate Dipotassium Tablets Usp 4389-53, NDC00047-0451-30, NDC00074-4389-53, NDC00228-3067-50, NDC00364-2201-05 of Abbott Laboratories Inc, Warner Lambert Ltd, Actavis Inc, Schein Henry Inc, Mylan Pharmaceuticals Inc with NSN 6505-01-252-0802.

NSN 6505-01-252-0802, National Stock Number, is a 13-digit serial number assigned by the US DLA to an item that is bought, stored, and sold via the federal supply chain. Unlike part numbers, NSNs are not arbitrary and follow a specific classification system.

Part Number List for NSN 6505012520802

Part No	Item Name	Manufacturer	QTY	RFQ
4389-53	Clorazepate Dipotassium Tablets Usp	Abbott Laboratories Inc	Avl	RFQ
NDC00047-0451-30	Clorazepate Dipotassium Tablets Usp	Warner Lambert Ltd	Avl	RFQ
NDC00074-4389-53	Clorazepate Dipotassium Tablets Usp	Abbott Laboratories Inc	Avl	RFQ
NDC00228-3067-50	Clorazepate Dipotassium Tablets Usp	Actavis Inc	Avl	RFQ
NDC00364-2201-05	Clorazepate Dipotassium Tablets Usp	Schein Henry Inc	Avl	RFQ
NDC00378-0030-05	Clorazepate Dipotassium Tablets Usp	Mylan Pharmaceuticals Inc	Avl	RFQ
NDC00536-4940-05	Clorazepate Dipotassium Tablets Usp	Rugby Group Inc	Avl	RFQ
NDC00591-0363-05	Clorazepate Dipotassium Tablets Usp	Danbury Pharmacal Inc	Avl	RFQ
NDC51672-4042-02	Clorazepate Dipotassium Tablets Usp	Taro Pharmaceuticals Usa Inc	Avl	RFQ

Characteristics Data of NSN 6505012520802

MRC	Criteria	Characteristic
AJCN	PROTECTIVE STORAGE FEATURE	SECURITY STORAGE
AKJA	ACTIVE MEDICAMENT MEDICINAL STRENGTH	3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT
CRLK	PRIMARY CONTAINER CONTENT QUANTITY	500.000 TABLETS
FEAT	SPECIAL FEATURES	SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION
CXCY	PART NAME ASSIGNED BY CONTROLLING AGENCY	CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 500S BT
CQCT	PRIMARY CONTAINER TYPE	BOTTLE

Similar NSN of 6505012520802

6505-00-001-3345	6505-00-001-7673	6505-00-001-7674
6505-00-001-9186	6505-00-003-3022	6505-00-003-3026
6505-00-003-5112	6505-00-003-5116	6505-00-004-6652